What Happened?
New York, NY-based C2i-Genomics Appointed Asaf Zviran as Chief Executive Officer, Co−Founder
About the Company
C2i Genomics is the first company to offer post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor`s DNA. Our liquid biopsy Whole Genome assay and cancer burden score will equip oncologists with vital timely information months to years before current monitoring methods are able to.
About the Person
Asaf Zviran is Chief Executive Officer, Co−Founder at C2i Genomics. Previously, Asaf held various senior HR leadership roles in the industry.
Info Source
News
Short Profile